Access cutting-edge pneumonia treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access pneumonia specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pneumonia treatment provided free
This is an international, open-label, stratified randomized controlled trial with Bayesian adaptive stopping rules to compare the effects of therapeutic-dose heparin vs. usual care pharmacological thromboprophylaxis on outcomes in patients admitted to hospital with community acquired pneumonia (CAP).
Sponsor: University of Manitoba
Check if you qualify for this pneumonia clinical trial in Chicago, IL
If you're searching for pneumonia treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pneumonia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.